Neuropace, Inc.
About
16.54USD-0.85 -4.89%
Closed • Updated at 06:04 GMT+00:00Market Cap$563.91M
Volume177.8K
Beta0.72
RSI51.07
Gross Margin78.29%
Neuropace, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Yesterday
NeuroPace to Highlight Expanding Role of Responsive Neuromodulation at the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Meeting
Yesterday
NeuroPace Announces FDA Approval of ECoG Assistant™, Advancing AI-Driven Epilepsy Care
Apr 29 2026
NeuroPace to Report First Quarter 2026 Financial Results on May 12, 2026
Apr 27 2026
NeuroPace Highlights Expanding Clinical Evidence Leadership with Published 3-Year Post-Approval Study (PAS) Results in Neurology and NAUTILUS Presentation at AAN 2026
Apr 10 2026
NeuroPace to Present at the 25th Annual Needham Virtual Healthcare Conference
Community Chat
Ask AI
Try asking